Document

We consent to the incorporation by reference in Registration Statement No. 333-276164 on Form F-3 and in Registration Statement No. 333-257834 on Form S-8 of our report dated April 4, 2024, relating to the consolidated financial statements of Innate Pharma and subsidiaries (the “Company”) (which report expresses an unqualified opinion), appearing in this Annual Report on Form 20-F of the Company for the year ended December 31, 2023.